thanks for jogging the memory regards ATL1102 what was most interesting as well is that ATL1102 has passed a phase 11 safety efficacy trial already and like as stated regarding antisense drugs because they all work very similar meaning they just change different strands of the RNA (is that right please correct me if I have it wrong here) thus boding well for the safety and efficacy of ATL1103. Well thats my take on it so really exciting stuff that the drugs are so closely related that they can sometimes predict in advance what could happen based on other similar drugs so for me this is a BIG thumbs up so thanks again for the reminder all IMO
technicals, page-23
-
- There are more pages in this discussion • 134 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.010(10.0%) |
Mkt cap ! $99.16M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.5¢ | 10.5¢ | $166.1K | 1.522M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 563549 | 10.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.0¢ | 382827 | 5 |
View Market Depth
| Last trade - 12.54pm 30/09/2024 (20 minute delay) ? |
| PER (ASX) Chart |